This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SGAs used to treat bipolar disorder are often effective at helping young patients’ mental health improve but can have significant sideeffects including elevated blood pressure and glucose, increased appetite, as well as weight gain.
Yet the media has led with “diabetes drug leads to major weight loss” Will doctors inform patients? Wegovy’s most common sideeffects were gastrointestinal problems, including nausea, diarrhea, and vomiting, which 80% of patients reported, according to USA Today.
It’s more about weighing the benefit against the potential sideeffects. Given the lack of new DRC studies, we decided to take some of the money we earned to let one of our team lead a quantitative online DTC study. TV spots are the number one way people learn about new pharma products.
With the rise of AI technologies, we could see significant advancements in cancer treatment, making it more efficient and potentially leading to a cure. By catching the disease early, patients have a higher chance of receiving successful treatment, and the cost of treatment can be significantly reduced.
Today patients and caregivers want to know more about the product’s sideeffects and cost, and they also want to hear from current patients. Two doctors I chatted with said they are getting requests from patients who want to lose weight and do not have diabetes. What can we learn from this?
New research from the US indicates that a prophylactic treatment before immunotherapy can significantly reduce the rate of cytokine release syndrome (CRS) in multiple myeloma patients. Immunotherapy drugs like teclistamab can result in potentially fatal sideeffects, including CRS and immune cell-associated neurotoxicity syndrome (ICANS).
In addition, the patient journey is different for each product category and audience. Some will lead to more online research, while others may not. The hottest pharma product is Lilly’s diabetes drug, hyped by the media as helping patients lose weight. Marketers need to know how and why patients went on therapy.
DTC ads do NOT lead to unnecessary Rxs. Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. 3hree: DTC marketing minimizes the sideeffects of prescription drugs – One of the top pages within prescription drug websites continues to be “safety information.”
A number of factors impact health literacy, including a patient’s receipt of appropriate written health communication materials, ability to accurately interpret written health-related information, and communication with providers. For example, such communication barriers have been associated with patients being more likely to be hospitalized.
DTC marketers spend a lot of time and money gaining insights into patients and caregivers. That information should be shared with HCPs and insurers to understand better the barriers and opportunities of treating patients. The research showed that patients wanted to understand how the drug works and the potential sideeffects.
Using the same ads to advertise prescription drugs repeatedly is a waste of money and doesn’t lead to sales. Each disease state has unique patient behaviors, and decision matrix’s for going from awareness to asking for an Rx. The MS market is a great example. Running T.V.
SUMMARY : DTC marketing is evolving as patients become more thoughtful about choosing treatment options. First, there is the misinformation on the web, and second, there is a fear of drug sideeffects that are applied because of the drugs used to treat and prevent—the pandemic. 6ix: Data is crucial even to patients.
Imagine a time when pharmaceutical ads simply told patients what to ask their doctor. Today, patient marketing is no longer a one-way street. This article dives deep into how patient marketing has changed, whats driving this transformation, and what strategies are leading the way for 2025 and beyond.
Rather than mentioning the brand, we sent a Tweet with “learn about the sideeffects of new products to treat psoriasis,” which linked to a page within the product website on sideeffects. It’s also imperative to understand that a social media post is NOT, alone, going to lead to a new Rx.
” So, are we supposed to believe that better images in DTC ads lead to patients asking for an Rx? Ad recall is essential for CPGs, but for prescription drugs, the question that’s missing is “what action did it lead to? What people seem to be interested in are drug sideeffects vs. efficacy.
Yet, the healthcare experience often begins with a decidedly analog ritual: The dreaded patient intake form. For too long, the administrative side of healthcare has lagged behind its clinical advancements. Its simple: Digital patient intake forms. What is Digital Patient Intake?
Google Trends has reported that the top search terms for Wegovy besides weight loss are “Wegovy cost” and “Wegovy sideeffects.” People want to know about product costs and, more importantly, product sideeffects. ” Can influencers persuade people to ask for Wegovy?
Since that time, Biogen’s MS drugs have faced intense competition as MS patients continue to vent on social media that the Biogen drug has nasty sideeffects. Knopman, a Mayo Clinic neurologist who treats Alzheimer’s patients and is a member of the FDA advisory committee. Washington Post.
However, patient uptake hasn’t matched rising market competition. And among patients who have tried preventive medications for migraine, 39% said they no longer took them. These low adoption rates highlight the need for more migraine-drug awareness and suggest that pharma marketers should explore new strategies to boost patient uptake.
After eight weeks of treatment, patients’ depression severity scores dropped by an average of 19.1 Treatment-related sideeffects included nausea and headache but were generally mild. “As The post Psilocybin-assisted therapy reduces depressive symptoms in cancer patients appeared first on European Pharmaceutical Review.
Jazz Pharmaceuticals has introduced a new prescription medication for patients with sleep apnea/narcolepsy that “helped adults get up to 9 hours of improved wakefulness in clinical studies at 12 weeks” and they’re using a flying pig on their DTC. First, the problem of sleep apnea. This DTC is an embaressment.
During one weekly status call, the Medical Affairs person commented that they were receiving reports from “the field” of a new sideeffect not listed in the label. It leads to clicks which leads to high advertising rates. Every pharma CEO should require that every employee has a KRA on focusing on patients.
MS patients are often more willing to try new treatments but are very wary of quality of life issues. However, clickstream analysis via Alexa clearly shows that TV ads also lead to searches for competitive treatments. Market research needs to step it up and give you qualitative insights into how patients respond to your DTC.
Repurposing cyclophosphamide may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, new research suggests. The study is assessing patients treated with cyclophosphamide and peripheral blood stem cell (PBSC) transplantation.
Ninety-four percent of advanced stage (3 or 4) classic Hodgkin lymphoma patients treated with nivolumab, a PD-1 checkpoint inhibitor plus AVD chemotherapy (N-AVD) had one-year progression-free survival (PFS), according to Phase III trial results. Then 487 were part of the BV-AVD group.
A new drug, part of a class of chemicals called potassium-channel openers, has demonstrated potential in offering relief to patients with focal epilepsy. Comparatively, patients given a placebo had on average 18 percent fewer seizures during the treatment phase of the trial, which lasted eight weeks.
In September, a group from Friedrich Alexander University Erlangen-Nuremberg reported that five patients with lupus achieved remission after an infusion of autologous chimeric antigen receptor (CAR)-T cells led to a deep depletion of B cells. All five patients achieved remission after three months.
For instance, while patients prioritize benefits and sideeffects, healthcare providers look for clinical evidence and efficacy. A campaign that shares a real patient success story can evoke trust and engagement. Missteps can lead to hefty fines and reputational damage. How can you ensure your strategy stands out?
One leading proponent of the approach – South San Francisco’s Nkarta – has just reported new results from an early-stage trial of one of its CAR-NK therapies that will likely add to the enthusiasm for the field. There are still questions about the durability of the effects however, as NK cells have a limited lifespan within the body.
Amgen’s new immunotherapeutic agent Tarlatamab has been shown in a Phase II trial to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer patients. The international DeLLphi-301study was investigated as a new anti-cancer treatment option for patients previously considered to be beyond treatment.
Used as a treatment for bipolar disorder and depression, lithium requires very accurate and sensitive dosing, with too little providing no therapeutic benefit but slightly too much potentially leading to unwanted side-effects. Another issue with the drug is the potential for poor patient compliance.
In a statement , the health technology assessment (HTA) organisation said that the two drugs were backed after an agreement with the two developers on pricing that will make them an option for around 3,450 NHS patients. NICE estimates that around 2,800 people are eligible for treatment with Piqray plus fulvestrant.
Psoriasis is a tricky disease to manage, as drawbacks and sideeffects loom with each and every type of treatment. But two new non-steroidal topicals were introduced this year — Dermavant Science’s Vtama and Arcutis Biotherapeutics’ Zoryve — and each one solves a long-time problem plaguing millions of psoriasis patients.
A new computer model has successfully simulated a clinical trial evaluating the efficacy of aducanumab and donanemab for Alzheimer’s disease (AD), establishing a gradual increase in dosage up to the maximum dose helps to minimise cognitive decline and limit sideeffects. . We’ve shown that this type of model can work.
— Watch the episode here Listen to the podcast here Surviving Cancer And Making An Impact To Cancer Patients’ Lives With Rob Ciaramitaro In this episode, we have with us another special guest and he goes by the name of Rob Ciaramitaro. Diagnostic products can change when patients discover their diseases.
With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. Lead Generation: HCPs looking for drug samples, whitepapers, or medical education can be driven to tailored landing pages.
Atopic dermatitis (AD) is a highly prevalent chronic dermatological disease, with symptoms which include itching, dry skin, severe pain, and inflammation – all of which create considerable stress in the daily lives of patients and often negatively affect their day-to-day and long-term well-being. However, sideeffects do happen.
Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. The answer is simple search engines and social platforms are where patients and HCPs find information. Lead Generation: Drive patient education sign-ups, HCP event registrations, and drug sample requests.
What’s so unique about DTC marketing is that all initiatives work together to drive a targeted patient behavior. On site at physicians office – Are patients asking about your product as a resut of being exposed to product information at the site of treatment. However, healthcare marketing is not CPGs or an eCommerce site.
Table of Contents Sr# Headings 1 Know Your Audience and Their Needs 2 Leverage Branded and Unbranded Content 3 Engage Responsibly and Transparently 4 Utilize Influencers and Patient Stories 5 Analyze and Optimize Regularly 1. Are you trying to engage healthcare professionals (HCPs), patients, or caregivers?
Left untreated, high levels of the amino acid become toxic to the brain and may lead to serious neurological and neuropsychological issues. PKU is a rare genetic disease that manifests at birth and is marked by an inability to break down phenylalanine (phe), an amino acid that is commonly found in many foods.
“At Cala, we’ve always been committed to expanding patient access and accelerating innovation in TAPS therapy for indications beyond essential tremor,” said Renee Ryan, CEO at Cala. “By By expanding into Parkinson’s disease, we are now able to bring this powerful treatment to additional patients who suffer from action hand tremors.”
Scientists at Brown University have designed an automated liquid chromatography tandem mass spectrometry (LC-MS/MS) system that allows clinicians to rapidly and easily process patient samples to determine levels of antidepressant drugs in the body. Too little and the patient may not experience the full benefit of the treatment.
Intrathecal (IT) (directly into the spinal fluid) and intravenous (IV) nivolumab (anti-PD-1) immunotherapy was found to be safe and improved survival in a subset of melanoma patients with leptomeningeal disease (LMD). Results of the immunotherapy study Across 25 patients, the median overall survival (OS) was 4.9
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content